Last news
Meraas unveils Dubai Design District residential masterplan, introducing a world-class waterfront neighbourhood

Meraas unveils Dubai Design District residential masterplan, introducing a world-class waterfront neighbourhood

DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ -- Meraas, a member of Dubai Holding Real Estate, has unveiled an expanded residential masterplan for Dubai Design District (d3), transforming the district into one of Dubai's most desirable creative-led...

Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA

Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally...

Bybit Launches Program to Upskill Sri Lankan Creators with Fully Sponsored Market Education Program

Bybit Launches Program to Upskill Sri Lankan Creators with Fully Sponsored Market Education Program

DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has launched a fully sponsored market literacy education initiative aimed at supporting financial literacy and responsible market...

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred...

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also...

JustMarkets Announces Boost Contest for All Clients

JustMarkets Announces Boost Contest for All Clients

HO CHI MINH CITY, Vietnam, Jan. 5, 2026 /PRNewswire/ -- JustMarkets, a worldwide broker with more than 12 years of experience in the online trading realm, is launching the Boost Contest, which represents a large-scale trading activity with the...

Patriot Memory Showcases Next-Generation Performance at CES 2026

Patriot Memory Showcases Next-Generation Performance at CES 2026

LAS VEGAS, Jan. 5, 2026 /PRNewswire/ -- Patriot Memory, a global leader in high-performance memory and storage solutions, will unveil its latest advancements at CES 2026, taking place January 6–9, 2026, in Las Vegas, Nevada. Building on decades of...

Colgate Honors Over 200 Years of Heritage with the Launch of the "Hong Kong Sentiments" Limited Edition Collection

Colgate Honors Over 200 Years of Heritage with the Launch of the "Hong Kong Sentiments" Limited Edition Collection

Introducing the Industry's First Oral Care "Blind Box" Series: Miniature City Landmarks Designed to Inspire Greater Smiles; Interactive 3D Posting Boxes and and Themed Pop-up Stations to Debut Across Hong Kong HONG KONG, Jan. 5, 2026 /PRNewswire/ --...

1 ... 8 9 10 11 12 13 14 15 16 ... 3478
menu
menu